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Strengths and limitations of this study
 ► This will be the first systematic review to synthesise 
evidence of neuromuscular adaptations in people 
with recurrent spinal pain (neck or low back pain) 
during a period of remission.
 ► This protocol is written following the recommen-
dations reported in version 6 of the Cochrane 
Handbook for Systematic Reviews of Interventions 
that will be published in mid-2019 (second edition 
of the Handbook).
 ► Neuromuscular changes will be evaluated con-
sidering a broad range of outcome domains, spe-
cifically muscle activity, spine kinematics, muscle 
properties, sensorimotor control and neuromuscular 
performance.
 ► In accordance with the Grading of Recommendations 
Assessment, Development, and Evaluation ap-
proach, the inclusion of observational studies reduc-
es the quality of evidence.
ABSTRACT
Introduction The course of spinal pain (neck or low back 
pain) is often described as episodic and intermittent, with 
more than one- third of people continuing to experience 
episodic symptoms 1 year after first onset. Although 
ongoing neuromuscular adaptations could contribute 
to recurrent episodes of pain, no systematic review has 
synthesised evidence of ongoing neuromuscular changes 
in people with recurrent spinal pain during a period of 
symptom remission.
Methods and analysis This protocol is developed and 
reported following the Preferred Reporting Items for 
Systematic Reviews and Meta- Analyses- P, the Update of 
the Cochrane Back and Neck Group guidelines and the 
Methodological Expectations of Cochrane Intervention 
Reviews. PubMed, Web of Science, MEDLINE, EMBASE, 
CINAHL, ZETOC, Google Scholar, grey literature sources 
and key journals will be searched up to September 2019. 
Observational studies investigating neuromuscular changes 
in people with recurrent spinal pain during a period of 
remission will be included. Neuromuscular function will be 
considered under five outcome domains of muscle activity, 
spine kinematics, muscle properties, sensorimotor control 
and neuromuscular performance. Two independent reviewers 
will search, screen studies, extract data and assess risk of 
bias (Newcastle- Ottawa Scale). Data will be synthesised 
per outcome domain. Where clinical and methodological 
homogeneity across studies exists, a random- effects 
meta- analysis will be conducted. Otherwise, results will 
be synthesised narratively. The overall quality of evidence 
will be assessed using the Grading of Recommendations, 
Assessment, Development and Evaluation guidelines.
Ethics and dissemination Findings of this review may 
aid the identification of factors that could contribute 
to spinal pain recurrence and aid the development of 
interventions for secondary prevention aimed at the 
restoration of optimal neuromuscular function. The results 
will be submitted for publication in a peer- reviewed journal 
and presented at conferences. No ethical approval was 
required.
PROSPERO registration number CRD42019141527.
InTROduCTIOn
Low back and neck pain (spinal pain) 
continue to be the leading cause of disability 
worldwide.1 The number of years lived with 
disability has increased by more than 50% 
since 1990, creating a ‘spinal pain epidemic’.1 2 
In particular, people aged between 25 and 64 
years are most affected by spinal pain1 and 
thus the economic impact is substantial due 
to work absences and healthcare cost.3
Spinal pain is a particularly challenging 
condition since the prognosis is often poor 
following an acute episode and many people 
experience recurrent pain.4–6 For instance, 
more than 50% and 30% of patients experi-
ence further neck or low back pain episodes, 
respectively, within the first year following a 
first episode.7 8 Indeed, the course of spinal 
pain is often described as repeated episodes 
of pain, commonly across a lifetime, with 
varying degrees of recovery between 
episodes. Summarising 10 cohort studies, 
Kongsted et al9 identified different patterns 
of low back pain progression, distinguishing 
between persistent, fluctuating, recurrent 
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and single episode trajectories. Conceptually, it is also 
necessary to distinguish between new painful episodes 
characterising recurrent patterns10 and the notion 
of flare, a sudden and severe increase of symptoms 
affecting persistent or fluctuating conditions.11 Recur-
rent episodes of pain were described by de Vet et al10 as 
periods of pain lasting for 1 day or more and separated 
by at least 1 month of symptom remission. Fluctuating 
patterns differ from recurrent pain because the former 
does not include period of remission, so patients 
continue to experience symptoms but with different 
level of intensity.9 10
Several factors may contribute to recurrent episodes of 
pain including ongoing maladaptive motor behaviour, 
neuromuscular deficits, impaired sensorimotor control 
and fear avoidance.12–15 More specifically, in people with 
spinal pain a number of common neuromuscular changes 
have been observed which have the potential to contribute 
to repeated episodes of pain. These include reduced 
muscle strength, endurance,16–19 range of motion,20 21 
increased muscle co- activation,22 23 poorer control of the 
deeper muscles,24 25 poorer proprioception and changes 
in the quality and variability of movement.26–29 Although 
these changes have been contextualised to be protec-
tive in nature30 31 and occur early following the onset of 
pain,32–34 they appear to be sustained beyond the acute 
phase13 35 36 and have the potential to contribute to chro-
nicity and repeated painful episodes.12 31 37 38 Although 
numerous studies have confirmed the presence of 
altered neuromuscular function in patients with chronic 
neck18 39 and back pain25 40 41 and systematic reviews 
have been conducted to critically appraise these studies, 
and synthesise findings,21 42–44 no systematic review has 
been conducted to evaluate evidence of neuromuscular 
changes during a period of remission in people with 
recurrent spinal pain. The assessment of patients during 
a period of remission allows to investigate neuromuscular 
function without pain interference.
The aim of this systematic review is to summarise the 
current literature to determine the evidence supporting 
the existence of ongoing neuromuscular adaptations 
in people with recurrent spinal pain during a period of 
remission. It is expected that this synthesis of evidence 
will influence clinical practice by highlighting the need to 
manage and restore neuromuscular function in addition 
to symptom suppression and will promote the relevance 
of interventions for secondary prevention.
METhOdS
The protocol of this review has been developed following 
the update of the Cochrane Back and Neck Group guide-
lines,45 the Methodological Expectations of Cochrane 
Intervention Reviews (MECIR)46 and the Preferred 
Reporting Items for Systematic Reviews and Meta- Analyses 
(PRISMA) Protocols (online supplementary file 1).47
Eligibility criteria
In order to detail the main elements of the systematic 
review, the PICOS framework will be used where P – Popu-
lation, I – Indicator, C – Comparator, O – Outcome(s) 
and S - Study design.47 48
Population
Adults (age ≥18 years old) with recurrent non- specific 
spinal pain (neck or low back pain) are the population of 
interest and adults without a history of spinal pain repre-
sent the control group. For the purpose of this review 
and in order to avoid the exclusion of relevant articles, 
the definition provided by de Vet et al10 will be partially 
considered due to the heterogeneity identified during 
the scoping search. Therefore, for the recurrent spinal 
pain group, we will consider studies where the individuals 
have experienced episodes of spinal pain on at least two 
occasions during the previous year.10 Participants with 
injury that resulted in a fracture or radiating, neuropathic 
pain will be excluded. Pain intensity reported before the 
outcome assessment will not represent an element of 
exclusion but it will be considered for further subgroup 
analysis (no pain vs minimal pain) as the initial scoping 
search identified that some studies define a period of 
remission to be minimal pain rather than absence of pain.
Indicator
The indicator of interest is the use of:
 ► Surface electromyography (EMG), intramuscular 
EMG, ultrasound and functional magnetic resonance 
imaging (fMRI) to measure axial muscle activity/
behaviour.49–52
 ► Motion analysis systems (eg, optoelectronic systems, 
inertial measurement unit sensors) to quantify spine 
kinematics.53
 ► Ultrasound and MRI to investigate muscle proper-
ties.54 55
 ► Dynamometry and performance testing to assess 
strength and endurance of axial muscles.
Therefore, all muscles (superficial and deep) that act 
on the spine and movements of the lumbar, thoracic and 
cervical regions will be considered.
Comparison
Between- group comparisons will be analysed consid-
ering people with recurrent spinal pain during a period 
of remission and healthy subjects without a history of 
spinal pain (neck or low back pain). Moreover, studies 
must include comparisons related to axial muscle activity, 
spine kinematics, sensorimotor control, muscle proper-
ties, strength and endurance during rest or tasks (static 
and/or dynamic).
Outcomes
The outcomes of interest are chosen based on the purpose 
of the review and the theoretical framework that has been 
suggested for people with spinal pain.31 37 38
Moreover, in accordance with the literature neuro-
muscular adaptations selected can influence long- term 
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Table 1 Outcome domains
Concept measured Broad outcome domains Narrow outcome domains
Neuromuscular adaptations of the spine Muscle activity  ► Amplitude of activity and its variability
 ► Timing of activation and its variability
Spine kinematics  ► Active range of motion
 ► Motor variability
 ► Quality of movement
Sensorimotor control  ► Proprioception
Muscle properties  ► Total cross- sectional area (CSA)
 ► Muscle CSA
 ► Extent of fat infiltration
Neuromuscular performance  ► Strength
 ► Endurance/fatigue
negative consequences and they could contribute to 
trigger future episodes of pain.31
The main concept investigated is the neuromuscular 
system; therefore, broad domains such as axial muscle 
activity, spinal kinematics, sensorimotor control, proper-
ties of the axial muscles and performance will be consid-
ered. In order to narrow the review focus, specific outcome 
domains are identified within the broad domains and are 
summarised in table 1.
Outcome domains are operationalised and different 
outcome measures are considered as described in the 
following paragraphs.
Muscle activity domain will comprise muscle timing 
(during predicted and non- predicted perturbations) 
and muscle amplitude. The outcome measures that will 
be extracted to report amplitude and muscle timing with 
EMG are the average rectified value or root mean square 
and the onset of activity. Moreover, EMG variability 
related to the timing and amplitude of muscle activity will 
be considered. In the measurements obtained by ultra-
sound, the change of muscle thickness compared to rest 
value represents the outcome measure that will be used to 
report on changes in muscle activity. For fMRI measure-
ments, parameters related to transverse relaxation time 
will be considered.51
Spine kinematics will comprise specific domains; motor 
variability, active range of motion and quality of move-
ment (accuracy and smoothness) during functional tasks 
or tests. It is not possible to specify a priori the outcome 
measures because they depend on the tasks and instru-
ments used.
Sensorimotor control of the spine will include proprio-
ception investigated through specific tests (eg, reposi-
tioning and movement detection).
Muscle properties recorded with ultrasound or MRI 
include features such as the extent of fat infiltration, 
muscle thickness and total muscle cross- sectional area.
Strength and endurance values of the axial muscles 
investigated with dynamometry will be considered. More-
over, endurance related data obtained with the Borg Scale 
or EMG features (mean frequency or median frequency) 
will be included.
Study design
Based on the scoping search, observational studies will be 
considered because they address the PICOS framework 
specified in the review question.
Information sources
The search will be conducted from inception to 1 
September 2019. Databases will include MEDLINE 
(OVID interface), EMBASE (OVID interface), CINAHL 
(EBSCO interface), ZETOC and Google Scholar. More-
over, specific Internet sites will be searched: PubMed, Web 
of Science and Cochrane Back and Neck Review Group.
The search process will be conducted using medical 
subject headings (MESH) where appropriate and rele-
vant text words associated with the concepts of this 
review. The search strategy will be done operationalising 
the PICOS framework and the main concepts that will be 
considered are related to the population and outcomes 
of interest. Words associated with them will be linked with 
the Boolean terms AND/OR:
POPULATION:
‘Recurrent’ (using OR for all possible synonyms, such 
as intermittent, history of, episodes)
AND
‘Spinal pain’ (using OR for all spine regions)
AND INDICATOR:
‘electromyography’ OR ‘motion analysis’ OR ‘dyna-
mometer’ (using OR for all possible synonyms and instru-
ments used)
AND OUTCOMES:
‘Spine kinematics’ OR ‘muscle activity’ OR ‘sensorim-
otor control’ OR ‘muscle properties’ OR ‘performance’ 
(words/synonyms related to these concepts will be used)
Hand- searching will be conducted based on the results 
of the scoping search and including journals relevant for 
this review topic, specifically the Journal of Electromyography 
and Kinesiology, Clinical Biomechanics, The Clinical Journal 
of Pain, Spine, Musculoskeletal Science and Practice, and the 
Journal of Orthopaedic and Sports Physical Therapy. The eligi-
bility of manuscripts included with hand searching will be 
defined using the PICOS framework. Relevant authors in 
the field will be contacted to obtain information about 
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Table 2 Characteristics of included studies
Study information Authors
Title
Year
Study design
Participant information Age, sex, sample size (healthy 
and recurrent pain group)
Pain details: location, inclusion 
criteria used for the recurrent 
pain group, pain level during 
assessment, pain intensity 
reported during episodes
Measurement methods Instrument used (EMG, 
ultrasound, fMRI, IMUs, etc)
Task or test performed (eg, 
postural control, joint relocation 
test, walking)
Muscles or regions of the spine 
assessed
Outcome of interest Muscle activity:
 ► Amplitude of activity and its 
variability
 ► Timing of activation and its 
variability
Spine kinematics:
 ► Active range of motion
 ► Motor variability
 ► Quality of movement
Sensorimotor control:
 ► Proprioception
Muscle properties:
 ► Total cross- sectional area 
(CSA)
 ► Muscle CSA
 ► Extent of fat infiltration
Performance:
 ► Strength
 ► Fatigue: self- reported (Borg 
scale)
 ► Fatigue: objectively measured 
(time to failure, EMG features, 
such as mean frequency and 
median frequency)
EMG, electromyography; fMRI, functional magnetic resonance 
imaging; IMU, inertial measurement unit.
unpublished or ongoing studies. In order to reduce the 
risk of publication bias, grey literature will be included 
considering the British National Bibliography for report 
literature, OpenGrey and dissertation abstracts. In accor-
dance with the MECIR standards,46 reference lists of 
included studies and relevant systematic reviews will be 
checked for any further studies.
Search strategy
The search will not be restricted by date, region or 
language limits. The specific search strategy has been 
defined in accordance with a Health Sciences Librarian 
with review searching experience. An example of the 
search strategy (draft MEDLINE search – Ovid interface) 
is reported in online supplementary file 2. Searching on 
MEDLINE (OVID interface) will be conducted using 
MESH. Based on other database selected, relevant terms 
will be adapted but search strategy consistency will be 
ensured.
data management
EndNote V.X9 (Clarivate Analytics) will be used to manage 
the data, including citations, abstracts and full- text of rele-
vant studies. A reviewer (VD) will upload studies during 
the searching process and duplicates will be removed. 
When the list of searched studies is completed, reviewers 
(VD and AG) will start the screening process. Full text of 
the papers that will be considered potentially eligible will 
be stored in EndNote V.X9.
Selection process
Based on the eligibility criteria, an electronic screening 
tool will be created and piloted. During the first stage of 
the screening process, two independent reviewers (VD 
and AG) will assess titles and abstracts against the eligi-
bility criteria. In an event of disagreement, reviewers will 
first attempt to resolve through discussion. If no consensus 
can be reached, a third reviewer (DF) will mediate the 
process. After the first screening process, full- text records 
will be obtained for potentially eligible studies. The full 
text screening will be conducted by two reviewers (VD 
and AG). During both stages of the screening process 
the agreement between the two reviewers will be assessed 
using the kappa statistic. The PRISMA flow diagram will 
used to summarise the study selection process.47
data extraction process
Data extraction will be performed independently by two 
reviewers (VD, AG) using a data extraction form developed 
and piloted a priori on a sub- group of studies. The data 
extraction form and table 2 will be customised based on 
the recommendations provided by Li et al,56 considering 
the eligibility criteria and aim of the review. If discrep-
ancies between reviewers arise, they will be resolved by 
discussion. A third reviewer (DF) will be consulted to 
mediate where necessary. The authors of the primary 
studies will be contacted if the description of methods 
or data reporting is unclear. Duplicate publications will 
be identified in order to reduce bias that could influence 
quantitative results. Multiple reports of the same study 
will be collated, and a specific report will be chosen. The 
decision of the selected report will be justified.
In accordance with McKenzie et al,57 data extraction 
and synthesis will be simplified following specific criteria:
 ► When an outcome of interest is measured more than 
one time, the first assessment will be considered. Base-
line measurements for cross- sectional comparisons 
with the healthy control group will be extracted in 
longitudinal studies or clinical trials.
 ► When an outcome of interest is measured with more 
than one tool, data will be selected based on the prop-
erties (reliability and validity) of the instrument.
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 ► Multiplicity of outcomes of the same domain (eg, 
strength of different muscles) will be reported and 
specific methods will be applied during data synthesis 
(see data synthesis section).
 ► Studies will be grouped based on the main outcome 
domain investigated; moreover, clinical and method-
ological diversity across studies will be analysed (see 
data synthesis section).
data items
Study characteristics will include details of participant, 
outcomes, outcome measures, study design and they are 
reported in table 2.
In order to reduce the impact of reporting bias, study 
authors will be contacted to obtain unpublished data or 
to clarify ambiguous results. However, if any uncertainty 
remains or the information provided by the author modi-
fies the eligibility of the study, the paper will be excluded 
and a specific explanation will be provided. Data will be 
extracted from the control and recurrent pain group. If 
more than two groups are investigated in a study, data will 
be collected only from the healthy control group and the 
one that meets the eligibility criteria.
Risk of bias
Two independent reviewers (VD, AG) will appraise 
the included studies using the Newcastle- Ottawa Scale 
(NOS).58 Discrepancies will be resolved with discussion. 
The risk of bias tool has been chosen based on the review 
question and the design of the primary studies detected 
during the scoping search (observational). There is not a 
firm consensus about the more suitable risk of bias tool 
for observational studies and health assessment groups 
have provided poorly defined recommendations.59 60 For 
example, in a recent review Quigley et al60 identified 48 
critical appraisal tools for non- randomised studies. Given 
its strengths, the NOS has been the most used tool in 
non- randomised studies; especially since it is quick to 
complete, adaptable, validated and usable in all kind of 
observational studies.58 61 62 Moreover, it assesses bias in the 
more relevant components of the studies included in this 
review; sample and outcomes. Considering the strengths 
of the NOS described previously, the case- control version 
will be used.58 The scale consists of three dimensions 
(selection, comparability, exposure) and eight items 
overall. The included studies will be assessed following 
the specific guidelines58 and a maximum of nine stars 
will be assigned to each paper (0–3=poor quality, 4–7=fair 
quality, 8–9=good quality). A table indicating the risk of 
bias in each study will be reported; moreover, detailed 
information for each dimension assessed by the NOS will 
be provided.
data synthesis
Results will be synthesised following the framework devel-
oped by McKenzie et al.63 Characteristics of each included 
study will be reported in a specific table. Then, studies 
and results will be grouped based on the main outcome 
domain investigated (muscle activity, spine kinematics, 
sensorimotor control, muscle properties, axial muscle 
performance) in the ‘Major Findings’ table. Moreover, 
data available for synthesis will be collected (mean and 
SD). The difference between healthy and recurrent spinal 
pain group will be reported using the standardised mean 
difference and 95% CI; data will be obtained directly 
from the paper or calculated using the available informa-
tion. Where relevant data are missing, the authors of the 
primary study will be contacted.
Random- effects meta- analysis (in accordance with the 
Cochrane Back and Neck Group)45 will be considered 
for a limited number of outcomes in order to reduce 
the risk of type I error (due to statistical multiplicity)64; 
therefore, the following outcomes are selected: muscle 
activity, muscle timing (during a postural perturbation), 
range of movements (including their variability) and 
muscle strength. These outcomes were selected consid-
ering the feasibility of their assessment in clinical prac-
tice and the theoretical framework of motor adaptation 
to pain.31 38 Briefly, the features considered appear to be 
adopted with a protective purpose but may still be present 
during a period of remission (potentially contributing to 
long- term negative consequences).31 38
A separate meta- analysis will be conducted for each 
selected outcome or dependent variable where possible.
In order to decide whether results can be summarised 
with statistical synthesis, heterogeneity across studies will 
be explored. First, clinical and methodological diversity 
across studies will be analysed by the two reviewers consid-
ering the following elements:
 ► Muscle or region of the spine investigated (lumbar, 
thoracic or cervical).
 ► Task performed.
 ► Outcome measure reported (for muscle amplitude 
outcomes only normalised value will be considered).
Whether clinical and methodological homogeneity 
across studies investigating the same outcome domain 
will be sufficient, statistical heterogeneity will be analysed. 
Disagreement between reviewers will be resolved by 
discussion and if it will persist a third reviewer (DF) will 
be consulted.
Based on the scoping search, a large number of 
studies included a small sample size, thus in accordance 
to Higgins et al,65 the Cochran’s Q test will provide low 
power in the detection of significant heterogeneity. 
Therefore, the amount of inconsistency between studies 
will be assessed using the I2 statistic.66 If heterogeneity 
will be substantial (I2 >50%), the results of the consid-
ered outcome will be described using the vote- counting 
procedure (direction of difference or no difference) 
and a narrative synthesis will be provided.67 Addition-
ally, if an adequate number of studies will be included,68 
subgroup analysis will be performed in meta- analysis split-
ting participants with recurrent spinal pain (neck or low 
back pain) in two subgroups—subjects with and without 
minimal pain during the assessment. This method will 
be used in order to explore whether the presence of 
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any pain influences motor control features. Subgroup 
comparison will be investigated using the fixed- effects 
model (between subgroups) described by Borenstein and 
Higgins.69
All the outcome results not included in the statistical 
synthesis will be described, when possible, with the vote- 
counting procedure or narratively67; moreover, in the 
group of people with recurrent spinal pain, differences in 
findings between asymptomatic and symptomatic subjects 
during the assessment will be reported. The narrative 
synthesis will be conducted following specific guidance 
and the steps provided by the Cochrane Consumers and 
Communication Review Group.70 71
Results will be shown based on the method of synthesis 
(quantitative or qualitative) and grouped considering the 
outcome domains. Risk of bias will not represent elements 
of restriction in the presentation of findings. Risk of 
publication bias will be analysed adopting the search 
strategies described in the information source section; 
particularly, results from references different to peer- 
reviewed articles will be included, as described by Page 
et al.72 For example, hand searching of grey literature on 
trial registers will be conducted and notable authors will 
be contacted to obtain information on unpublished data 
or ongoing works.
Confidence in cumulative estimate
Quality of findings (certainty) will be assessed using the 
Grading of Recommendations Assessment, Development, 
and Evaluation (GRADE) approach.73 74 The GRADE 
process is ‘outcome centric’; therefore, the quality of 
evidence will be analysed for each outcome domain 
included in the PICOS.75 In accordance with GRADE and 
considering that it is not possible to manipulate the inde-
pendent variable (pain remission/no history of pain), the 
observational studies included will be considered a low- 
quality source of evidence.73 75 After this initial consider-
ation, the certainty of evidence for each outcome across 
studies can be increased or decreased following specific 
criteria. Risk of bias, inconsistency, indirectness, impre-
cision and publication bias are reasons for lower quality 
of evidence.76 On the other hand, large effect size, dose–
response gradient and plausible confounding biases that 
underestimate the effect size are reasons to upgrade the 
certainty of evidence for the considered outcome across 
studies.76 Based on these criteria, GRADE rates the level 
of certainty for each outcome in four categories: ‘High’, 
‘Moderate’, ‘Low’ and ‘Very Low’.76 The GRADE guide-
lines provide detailed information on the assessment of 
the quality of evidence for observational studies.74 For 
example, study limitations to consider in observational 
studies during the evaluation of the strength of evidence 
are suggested.77
Patient and public involvement
The protocol was presented within patient and public 
involvement meetings in order to discuss the topic and 
obtain feedback for the review and future projects. 
Patients will not be involved in the analysis and data 
collection of the systematic review.
Implication of results
The natural course of spinal pain (neck or low back pain) 
is not straightforward and different patterns of pain 
progression have been described. A previous episode of 
pain is one of the most relevant factors for future pain 
recurrences. Evidence has shown the role and relation 
between neuromuscular changes and pain in persistent 
musculoskeletal disorders and recovery of neuromus-
cular function has become an important component in 
rehabilitation. However, the focus for the management 
of acute pain is limited to pain management and resolu-
tion rather than full functional rehabilitation. The results 
of this systematic review may identify relevant neuromus-
cular adaptations that could play a role in the recurrent 
nature of spinal pain with the potential to therefore influ-
ence clinical practice.
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